Swiss Pharma Stock News

Straumann Holding (SWX:STMN) is positioned for substantial growth, with earnings projected to rise by 20.89% annually and revenue expected to grow by 8.6% per year, outpacing the Swiss market. Despite challenges such as a decline in net profit margin and a significant one-off loss, the company is leveraging opportunities in new markets and investing in AI technology to enhance efficiency. The following report delves into Straumann's competitive advantages, critical issues affecting...

It's been a mediocre week for Ypsomed Holding AG ( VTX:YPSN ) shareholders, with the stock dropping 11% to CHF364 in...

Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...

When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses is...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you...

Chocoladefabriken Lindt & Sprüngli (VTX:LISN) has had a rough three months with its share price down 8.8%. However...

If you love investing in stocks you're bound to buy some losers. But the long term shareholders of Tecan Group AG...

VAT Group AG ( VTX:VACN ) received a lot of attention from a substantial price movement on the SWX over the last few...

Key Insights Accelleron Industries' estimated fair value is CHF45.01 based on 2 Stage Free Cash Flow to Equity...

One of the biggest stories of last week was how LEM Holding SA ( VTX:LEHN ) shares plunged 24% in the week since its...

Alcon ( VTX:ALC ) Third Quarter 2024 Results Key Financial Results Revenue: US$2.45b (up 5.4% from 3Q 2023). Net...

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 19x, you may consider...

Key Insights Bellevue Group's significant insider ownership suggests inherent interests in company's expansion 50% of...

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But investors can...

Key Insights Romande Energie Holding's significant state or government ownership suggests that the key decisions are...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

LEM Holding SA ( VTX:LEHN ) shareholders that were waiting for something to happen have been dealt a blow with a 34...

The latest earnings report from Barry Callebaut AG ( VTX:BARN ) disappointed investors. We did some digging and believe...

Adecco Group AG's ( VTX:ADEN ) earnings announcement last week didn't impress shareholders. While the headline numbers...

Temenos (SWX:TEMN) has reported a strong third-quarter performance with a 15% year-over-year revenue increase, driven by robust demand for its cloud solutions. The recent appointment of Barb Morgan as Chief Product and Technology Officer is expected to further enhance innovation and expand the company's global reach. In the following discussion, key areas such as financial health, competitive pressures, and future growth prospects will be explored.

When you see that almost half of the companies in the Aerospace & Defense industry in Switzerland have price-to-sales...

With a price-to-earnings (or "P/E") ratio of 22.5x Galenica AG ( VTX:GALE ) may be sending bearish signals at the...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Key Insights Using the 2 Stage Free Cash Flow to Equity, PolyPeptide Group fair value estimate is CHF25.02 PolyPeptide...